Preethi Korangath
Overview
Explore the profile of Preethi Korangath including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
589
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Carlton H, Salimi M, Arepally N, Bentolila G, Sharma A, Bibic A, et al.
Adv Funct Mater
. 2025 Jan;
35(2):2412321.
PMID: 39882193
Magnetic particle imaging (MPI) is an emerging modality that can address longstanding technological challenges encountered with magnetic particle hyperthermia (MPH) cancer therapy. MPI is a tracer technology compatible with MPH...
2.
Song M, Ivkov R, Korangath P
Nanoscale Adv
. 2024 Nov;
7(1):209-218.
PMID: 39569333
Nanoparticles can exert immune modulating effects in a host depending on composition, mode of administration, and type of disease. Although the specific mechanisms of nanoparticle-induced immune responses remain unclear, their...
3.
Korangath P, Jin L, Yang C, Healy S, Guo X, Ke S, et al.
ACS Nano
. 2024 Apr;
18(15):10509-10526.
PMID: 38564478
Systemic exposure to starch-coated iron oxide nanoparticles (IONPs) can stimulate antitumor T cell responses, even when little IONP is retained within the tumor. Here, we demonstrate in mouse models of...
4.
Carlton H, Attaluri A, Korangath P, Arepally N, Ivkov R
Proc ASME Summer Heat Transf Conf
. 2023 Oct;
2023.
PMID: 37860628
The dynamic nature of perfusion in living tissues, such as solid tumors during thermal therapy, produces challenging spatiotemporal thermal boundary conditions. Changes in perfusion can manifest as changes in convective...
5.
Healy S, Henderson E, Ke S, Kelly J, Simons B, Hu C, et al.
Nanotheranostics
. 2023 Jul;
7(4):393-411.
PMID: 37426881
The biological influence of physicochemical parameters of "targeted" nanoparticles on their delivery to cancer tumors remains poorly understood. A comparative analysis of nanoparticle distributions in tumors following systemic delivery across...
6.
Sousa-Junior A, Yang C, Korangath P, Ivkov R, Bakuzis A
Int J Mol Sci
. 2022 Dec;
23(24).
PMID: 36555306
A promise of cancer nanomedicine is the "targeted" delivery of therapeutic agents to tumors by the rational design of nanostructured materials. During the past several decades, a realization that in...
7.
Wang G, Kumar A, Ding W, Korangath P, Bera T, Wei J, et al.
Proc Natl Acad Sci U S A
. 2022 Jun;
119(24):e2200200119.
PMID: 35675429
The human transferrin receptor (TFR) is overexpressed in most breast cancers, including preneoplastic ductal carcinoma in situ (DCIS). HB21(Fv)-PE40 is a single-chain immunotoxin (IT) engineered by fusing the variable region...
8.
Liporagi Lopes L, Korangath P, Dos Santos Jr S, Gabrielson K, Ivkov R, Casadevall A
Antimicrob Agents Chemother
. 2022 Mar;
66(4):e0239921.
PMID: 35293784
Cryptococcosis is a devastating fungal disease associated with high morbidity and mortality even when treated with antifungal drugs. Bionized nanoferrite (BNF) nanoparticles are powerful immunomodulators, but their efficacy for infectious...
9.
Korangath P, Ivkov R
Bio Protoc
. 2021 Mar;
10(22):e3822.
PMID: 33659474
A clear understanding of nanoparticle interactions with living systems at the cellular level is necessary for developing nanoparticle-based therapeutics. Magnetic iron oxide nanoparticles provide unique opportunities to study these interactions...
10.
Han L, Korangath P, Nguyen N, Diehl A, Cho S, Teo W, et al.
Front Oncol
. 2021 Feb;
10:581459.
PMID: 33520697
Blocking tumor angiogenesis is an appealing therapeutic strategy, but to date, success has been elusive. We previously identified HEYL, a downstream target of Notch signaling, as an overexpressed gene in...